共 50 条
Relative ellipsoid zone reflectivity and its association with disease severity in age-related macular degeneration: a MACUSTAR study report
被引:0
作者:
Marlene Saßmannshausen
Charlotte Behning
Ben Isselmann
Matthias Schmid
Robert P. Finger
Frank G. Holz
Steffen Schmitz-Valckenberg
Maximilian Pfau
Sarah Thiele
机构:
[1] University of Bonn,Department of Ophthalmology
[2] University of Bonn,GRADE Reading Center
[3] University of Bonn,Institute for Medical Biometry, Informatics and Epidemiology
[4] University of Utah,John A. Moran Eye Center, Department of Ophthalmology and Visual Sciences
[5] National Eye Institute,Ophthalmic Genetics and Visual Function Branch
[6] University of Freiburg,Universitaetsklinikum Freiburg (UKLFR), Department of Ophthalmology
[7] University Hospital of Cologne,Department of Ophthalmology
[8] UPMC-Sorbonne Université,Quinze
[9] University Vita Salute-Scientific Institute of San Raffael,Vingts National Ophthalmology Hospital
[10] AIBILI Association for Innovation and Biomedical Research on Light and Image (AIBILI),Department of Ophthalmology
[11] Copenhagen University,Department of Ophthalmology, Rigshospitalet
[12] City University London,Glostrup
[13] Leiden University Medical Center,Department of Ophthalmology
[14] BAYER AG,Centro Hospitalar de Sao Joao EPE (Hospital Sao Joao), Department of Ophthalmology
[15] Novartis Pharma AG,Department of Ophthalmology Luigi Sacco Hospital
[16] University of Sheffield,Clinical Trial Unit, Department of Ophthalmology
[17] University College London (UCL),Department of Ophthalmology
[18] Fondation Voir et Etendre,Ophthalmology and Vision Sciences
[19] Porto Medical School,Stichting Katholieke Universiteit/Radboud University Medical Center (SRUMC)
[20] University of Milan,Department of Ophthalmology
[21] Carl Zeiss Meditec,STZ Biomed and STZ Eyetrial at the Center of Ophthalmology
[22] AG,Ludwig
[23] Gloucestershire Hospitals NHS Foundation Trust,Maximilians
[24] St. Franziskus Hospital,Universitaet Muenchen (LMU)
[25] The Queen’s University and Royal Group of Hospitals Trust,Centre Hospitalier Intercommunal de Creteil (HIC)
[26] Radbound University,undefined
[27] Nijmegen Medical Center,undefined
[28] University of Ulm,undefined
[29] University Hospital Tuebingen,undefined
[30] F. Hoffmann-La Roche Ltd,undefined
[31] Centre Hospitalier National d’Opthalmologie des Quinze-Vingts,undefined
[32] G. B. Bietti Eye Foundation-IRCCS,undefined
[33] University Eye Hospital,undefined
[34] European Clinical Research Infrastructure Network (ECRIN),undefined
[35] University Eye Clinic,undefined
[36] Centre Hospitalier Creteil,undefined
[37] Moorfields Eye Hospital NHS Foundation Trust (MBRC),undefined
来源:
Scientific Reports
|
/
12卷
关键词:
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Quantification of the relative ellipsoid zone reflectivity (rEZR) might be a structural surrogate parameter for an early disease progression in the context of age-related macular degeneration (AMD). Within the European multicenter, cross-sectional MACUSTAR study, we have devised an automatic approach to determine the mean rEZR [arbitrary units, AU] at two independent visits in SD-OCT volume scans in study participants. Linear mixed-effects models were applied to analyze the association of AMD stage and AMD associated high-risk features including presence of pigmentary abnormalities, reticular pseudodrusen (RPD), volume of the retinal-pigment-epithelial–drusenoid-complex (RPEDC) with the rEZR. Intra-class correlation coefficients (ICC) were determined for rEZR reliability analysis. Within the overall study cohort (301 participants), we could observe decreased rEZR values (coefficient estimate ± standard error) of − 8.05 ± 2.44 AU (p = 0.0011) in the intermediate and of − 22.35 ± 3.28 AU (p < 0.0001) in the late AMD group. RPD presence was significantly associated with the rEZR in iAMD eyes (− 6.49 ± 3.14 AU; p = 0.0403), while there was a good ICC of 0.846 (95% confidence interval: 0.809; 0.876) in the overall study cohort. This study showed an association of rEZR with increasing disease severity and the presence of iAMD high-risk features. Further studies are necessary to evaluate the rEZR’s value as a novel biomarker for AMD and disease progression.
引用
收藏
相关论文